Effects of peroxynitrite and lipopolysaccharide on mitotic activity of C6 glioma cells.
Peroxynitrite is one of the most potent neurotoxic agents with multiple targets in neurons and glial cells. This study addressed a question of whether peroxynitrite-mediated cytotoxicity can be prevented by Escherichia coli lypopolisaccharide (LPS) due to its mitogenic activity towards C6 glioma cells. A number of characteristic morphological changes (processes impairments, nuclei modifications, cytoplasm vacuolization) and apoptotic cells were observed in the cell culture after 24-h treatment with 3-morpholinosyndnonimine (SIN-1), a well-known donor of peroxynitrite. These morphological changes were clearly associated with a SIN-1 dose-dependent increase in the number of pathological mitoses as well as with SIN-1 inhibition of the menadione-induced, lucigenin-enhanced chemiluminescence of C6 glioma cells, an independent indicator of mitotic activity of these cells. The mitotic index of C6 glioma cells increased in response to LPS and underwent non-uniform changes depending on SIN-1 concentrations. At a mitogenic concentration of 100 ng/ml, LPS reduced significantly the toxicity of SIN-1 determined as the accumulation of pathological mitoses, thus acting as a protective agent. Taken together, our findings indicate that SIN-1 specifically impairs the mitotic process in C6 glioma cells, and provide the first evidence that antimitotic effects of peroxynitrite can be restored by LPS.
Kulahava
Tatsiana A
TA
Department of Biophysics, Physical Faculty, Belarusian State University, Skaryny ave.4, 220050 Minsk, Belarus. tatyana_kulagova@tut.by
Semenkova
Galina N
GN
Kvacheva
Zinaida B
ZB
Cherenkevich
Sergey N
SN
Timoshenko
Alexander V
AV
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D045744:Cell Line, Tumor; D004926:Escherichia coli; D005910:Glioma; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008163:Luminescent Measurements; D008934:Mitogens / Q000494:pharmacology*; D008938:Mitosis / Q000187:drug effects*; D008981:Molsidomine / Q000031:analogs & derivatives / Q000633:toxicity; D020030:Nitric Oxide Donors / Q000633:toxicity; D030421:Peroxynitrous Acid / Q000502:physiology*; D051381:Rats
D008070:Lipopolysaccharides; D008934:Mitogens; D020030:Nitric Oxide Donors; D030421:Peroxynitrous Acid; C002385:linsidomine; D008981:Molsidomine